Literature DB >> 7512037

Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes.

S L Parry1, M J Holman, J Hasbold, G G Klaus.   

Abstract

It is widely accepted that extensive cross-linking of surface immunoglobulin (sIg) receptors on mature B cells promotes their activation and progression through the cell cycle. A commonly employed method to maximize receptor cross-linking via anti-receptor antibodies is to immobilize them on tissue culture plastic. We show here that immobilizing monoclonal anti-mu or anti-delta antibodies, which are mitogenic in solution, on plastic abrogates their capacity to induce DNA synthesis in mature murine B cells, even in the presence of interleukin-4 (IL-4). The cells do become abortively activated, as evidenced by up-regulation of major histocompatibility complex class II antigen levels, but subsequently virtually all of them die, manifesting DNA fragmentation characteristic of apoptosis. The induction of apoptosis is abrogated by the inclusion of either IL-4 or anti-CD40 antibodies in the cultures, with the two stimuli acting in concert. We believe that the system represents a polyclonal model of clonal deletion tolerance in mature B cells, such as may be induced under physiological conditions by antigens with repeating epitopes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512037     DOI: 10.1002/eji.1830240429

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Antigen receptor-initiated signals for B cell development and selection.

Authors:  J G Monroe
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

2.  Properties of mouse CD40: differential expression of CD40 epitopes on dendritic cells and epithelial cells.

Authors:  T K Van Den Berg; J Hasbold; C Renardel De Lavalette; E A Döpp; C D Dijkstra; G G Klaus
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS.

Authors:  H Helmby; G Jönsson; M Troye-Blomberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.

Authors:  S Marshall-Clarke; G Owen; L Tasker
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

5.  Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice.

Authors:  K J Erb; B Rüger; M von Brevern; B Ryffel; A Schimpl; K Rivett
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

6.  CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Authors:  Karen M Haas; Kristen L Johnson; James P Phipps; Cardinal Do
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

7.  The molecular mechanism in activation-induced cell death of an Ag-reactive B cell clone.

Authors:  T Hamano; T Iwasaki; A Ogata; N Hashimoto; E Kakishita
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

8.  Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

9.  Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.

Authors:  E Racila; R H Scheuermann; L J Picker; E Yefenof; T Tucker; W Chang; R Marches; N E Street; E S Vitetta; J W Uhr
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Negative selection of human germinal center B cells by prolonged BCR cross-linking.

Authors:  L Galibert; N Burdin; C Barthélémy; G Meffre; I Durand; E Garcia; P Garrone; F Rousset; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.